Sonora Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Sonora Investment Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$8K	Hold	11	–	–	﹤0.01%	809
2021 Q2	$7K	Hold	11	–	–	﹤0.01%	759
2021 Q1	$6K	Hold	11	–	–	﹤0.01%	1455
2020 Q4	$6K	Hold	11	–	–	﹤0.01%	1392
2020 Q3	$6K	Hold	11	–	–	﹤0.01%	1384
2020 Q2	$5K	Hold	11	–	–	﹤0.01%	1345
2020 Q1	$4K	Hold	11	–	–	﹤0.01%	1327
2019 Q4	$4K	Buy	+11	New	+$3.88K	﹤0.01%	1462
2019 Q3	–	Sell	-11	Closed	-$3K	–	1718
2019 Q2	$3K	Hold	11	–	–	﹤0.01%	1507
2019 Q1	$3K	Buy	+11	New	+$2.97K	﹤0.01%	1334
2015 Q4	–	Sell	-35	Closed	-$5K	–	823
2015 Q3	$5K	Buy	+35	New	+$5.04K	﹤0.01%	697

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sonora Investment Management's BIO Position: Q3 2021 in Review

Sonora Investment Management held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2021 at 11 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #809.

Sonora Investment Management first reported a position in BIO in Q3 2015 and has held it in 11 quarters since. 508 funds tracked by Wall St. Rank hold BIO as of Q3 2021.

Sonora Investment Management held 11 shares of Bio-Rad Laboratories Class A worth $8K as of Q3 2021.
Sonora Investment Management left its Bio-Rad Laboratories Class A share count unchanged in Q3 2021.
Bio-Rad Laboratories Class A made up ﹤0.01% of Sonora Investment Management's portfolio in Q3 2021, its #809 holding.
Sonora Investment Management first reported a position in Bio-Rad Laboratories Class A in Q3 2015 and has held it in 11 quarters since.
508 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.